Molecular Characterization of the Acute Inflammatory Response to Infections with Gram-Negative versus Gram-Positive Bacteria

ABSTRACT Sepsis caused by gram-negative bacteria and that caused by gram-positive bacteria often manifest similar clinical features. We investigated plasma proinflammatory cytokine profiles in patients with sepsis due to gram-positive and gram-negative bacteria and studied the cytokine production and differential gene regulation of leukocytes stimulated ex vivo with Escherichia coli lipopolysaccharide or heat-killed Staphylococcus aureus. Concentrations of tumor necrosis factor alpha, interleukin 1 receptor antagonist (IL-1Ra), IL-8, IL-10, IL-18 binding protein, procalcitonin, and protein C in plasma did not differ between patients with sepsis due to gram-negative and gram-positive bacteria. However, plasma IL-1β, IL-6, and IL-18 concentrations were significantly higher in patients with sepsis due to gram-positive bacteria. Ex vivo stimulation of whole blood with heat-killed S. aureus markedly increased IL-1β and IL-18 levels more than E. coli lipopolysaccharide stimulation. Microarray analysis revealed at least 359 cross-validated probe sets (genes) significant at the P < 0.001 level whose expression discriminated among gram-negative-organism-stimulated, gram-positive-organism-stimulated, and unstimulated whole-blood leukocytes. The host inflammatory responses to gram-negative and gram-positive stimuli share some common response elements but also exhibit distinct patterns of cytokine appearance and leukocyte gene expression.

[1]  S. Akira,et al.  Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. , 2002, International immunology.

[2]  E. Lander,et al.  Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Ash A. Alizadeh,et al.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Singer,et al.  Regulation of Staphylococcus aureus-mediated activation of interleukin-18 in peripheral blood mononuclear cells. , 2002, European Cytokine Network.

[5]  M. Kurimoto,et al.  Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. , 2001, Shock.

[6]  C. Dinarello.  Novel targets for interleukin 18 binding protein , 2001, Annals of the rheumatic diseases.

[7]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[8]  G. Fantuzzi,et al.  A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. , 2001, Cytokine.

[9]  S. Akira,et al.  Toll-like receptors; their physiological role and signal transduction system. , 2001, International immunopharmacology.

[10]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[11]  L. Moldawer,et al.  Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target? , 2001, Immunology letters.

[12]  R. Dziarski,et al.  Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and Endotoxin* , 2000, The Journal of Biological Chemistry.

[13]  S. Foster,et al.  Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model , 2000, Infection and Immunity.

[14]  D. Fry.  Sepsis Syndrome , 2000, The American surgeon.

[15]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[16]  L. Moldawer,et al.  Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock. , 1999, Surgery.

[17]  S. Opal,et al.  Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? , 1999, Critical care medicine.

[18]  K. Reinhart,et al.  Treating patients with severe sepsis. , 1999, The New England journal of medicine.

[19]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[20]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Vincent.  Search for effective immunomodulating strategies against sepsis , 1998, The Lancet.

[22]  C. Natanson,et al.  Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. , 1997, Critical care medicine.

[23]  A. Baue.  Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? , 1997, Archives of surgery.

[24]  J. Vallés,et al.  Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Rosenblatt,et al.  Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. , 1997, Clinical Infectious Diseases.

[26]  C. Thiemermann,et al.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Cavaillon,et al.  Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide , 1994, Infection and immunity.

[28]  R. Bone,et al.  Gram-positive organisms and sepsis. , 1994, Archives of internal medicine.

[29]  J. Parrillo.  Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.

[30]  U. Andersson,et al.  Endotoxin and Staphylococcus aureus enterotoxin A induce different patterns of cytokines. , 1992, Cytokine.

[31]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[32]  F. Ognibene,et al.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.

[33]  A C Allison,et al.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. , 1990, The Journal of clinical investigation.

[34]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.